Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt

Journal of Medical Virology

Volumn 60, Issue 2, 2000, Pages 177-181

  Gad, Amal ^a,b   Tanaka, Eiji ^a,b   Orii, Kohji ^a   Kafumi, Todoriki ^a   Serwah, Abed El Hamid ^b   El Sherif, Asem ^b   Nooman, Zohair ^b   Kiyosawa, Kendo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Chronic hepatitis; Hepatitis B virus; Hepatitis C virus

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD DONOR; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; EGYPT; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; TORQUE TENO VIRUS; VIRUS REPLICATION;

ADULT; AGED; BLOOD DONORS; CHRONIC DISEASE; DNA, VIRAL; EGYPT; FEMALE; HEPATITIS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATITIS VIRUSES; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SCHISTOSOMIASIS; SEROEPIDEMIOLOGIC STUDIES; VOLUNTARY WORKERS;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS; TT VIRUS;

EID: 0033987483     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200002)60:2<177::AID-JMV12>3.0.CO;2-Z     Document Type: Article

References (30)

1. Arthur RR, Hassan NF, Abdallah MY, El-Sharkawy MS, Saad MD, Hackbart BG, Imam IZ. 1997. Hepatitis C antibody prevalence in blood donors in different governates in Egypt. Trans R Soc Trop Med Hyg 9:271-274.
2. Charlton M, Adjei P, Poterucha J, Zein N, Moure B, Therneau T, Krom R, Wiesner R. 1998. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 28:839-842.
3. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, and Edelman R. 1993. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49:440-447.
4. El Gohary A, Hassan A, Nooman Z, Lavanchy D, Mayerat C, El Ayat A, Fawaz N, Gobran F, Ahmed M, Kawano F. 1995. High prevalence of hepatitis C virus among urban and rural population group in Egypt. Acta Tropica 59:155-161.
5. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C. 1993. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 104:549-555.
6. Höhne M, Berg T, Muller AR, Schreier E. 1998. Detection of sequences of TT virus, a novel DNA virus, in German patients. J Gen Virol 79:2761-2764.
7. Hoofnagle JH, Dusheiko GM, Sheeff LB. 1981. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 94:744-748.
8. Hyams KC, Mansour MM, Massoud A, Dunn MA. 1987. Parenteral antischistosomal therapy: a potential risk factor for hepatitis B infection. J Med Virol 23:109-114.
9. Kamel MA, Miller FD, el Masry AG, Zakaria S, Khattab M, Essmat G, Ghaffar YA. 1994. The epidemiology of Schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitai 88:501-509.
10. Kawamura DM, Gill K, Beavers SE. 1992. Liver. In: Kawamura DM, editor. Diagnostic medical sonography: a guide to clinical practice. Philadelphia: JB Lippincott p 91-149.
11. Kodali VP, Gordon SC, Silverman AL, McCray DG. 1994. Cryptogenic liver disease in the United States: further evidence for non-A, non-B and non-C hepatitis. Am J Gastroenterol 89:1836-1839.
12. Krawczynski K. 1997. Novel hepatitis agents: the significance of clinical and experimental studies; an overview. J Gastroenterol Hepatol 12:193-194.
13. Matsumoto A, Tanaka E, Suzuki T, Ogata H, Kiyosawa K. 1994. Viral and host factors that contribute to efficacy of interferon-α2a therapy in patients with chronic hepatitis C. Dig Dis Sci 39:1273-1280.
14. Mushahwar IK, Erker JC, Muerhoff AS, Leary TP, Simons JN, Birkenmeyer LG, Chalmers ML, Pilot-Matias TJ, Dexai SM. 1999. Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci USA 96:3177-3182.
15. Naoumov NV, Petrova EP, Thomas MG, Williams R. 1998. Presence of a newly discovered human DNA virus (TTV) in patients with liver disease. Lancet 352:195-197.
16. Niel C, de Oliveira JM, Ross RS, Gomes SA, RoggendorfM, Viazov S 1999. High prevalence of TT virus infection in Brazilian blood donors. J Med Virol 57:259-263.
17. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in post-transfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241:92-97.
18. Nooman ZM, Hassan AH, Mishriky AM, Ragheb M, Abu Saif AN, Abaza SM, Serwah AA, Kamel M, Fouad M. 1995. The use and limitation of ultrasonography in the diagnosis of liver morbidity attributable to Schistosoma mansoni infection in community based surveys. Memorias do Instituto Oswaldo Cruz, Rio de Janeiro 90:147-154.
19. Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M. 1998a. Fecal excretion of a non-enveloped DNA virus (TTV) associated with post-transfusion non-A-G hepatitis. J Med Virol 56:128-132.
20. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M. 1998b. Molecular cloning and characterization of a novel DNA virus (TTV) associated with post-transfusion hepatitis of unknown etiology. Hepatol Res 10:1-16.
21. Orii K, Tanaka E, Umemura T, Rokuhara A, Iijima A, Yoshisawa K, Imai H, Kiyosawa K. 1999. Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis. Hepatol Res 14:161-170.
22. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A. 1993. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:1529-1533.
23. Poovorawan Y, Theamboonlers A, Jantaradsamee P, Kaew-in N, Hirsch P, Tangkitvanich P. 1998. Hepatitis TT virus infection in high-risk groups. Infection 26:355-358.
24. Prescott LE, Simmonds P. 1998. Global distribution of transfusion-transmitted virus. New Engl J Med 339:776-777.
25. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM. 1998. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 352:191-194.
26. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. 1998a. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res 12: 233-239.
27. Takahashi K, Ohta Y, Mishiro S. 1998b. Partial 2.4-Kb sequences of TT virus (TTV) genome from eight Japanese isolates: diagnostic and phylogenetic implications. Hepatol Res 12:111-120.
28. Tanaka H, Okamoto H, Luengrojanakul P, Chainuvati T, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. 1998. Infection with an unenveloped DNA virus (TTV) associated with post-transfusion non-A to G hepatitis in hepatitis patients and healthy blood donors in Thailand. J Med Virol 56:234-238.
29. Umemura T, Tanaka E, Ota M, Orii K, Yoshizawa K, Imai H, Sodeyama T, Kiyosawa K. 1999. TT virus infection in areas of high- and non-endemicity for hepatitis C. Hepatol Res 13:212-220.
30. Yamamoto T, Kajino K, Ogawa M, Gotoh I, Matsuoka S, Suzuki K, Moriyama M, Okubo H, Kudo M, Arakawa Y, Hino O. 1998. Hepatocellular carcinoma infected with the novel TT DNA virus lack viral integration. Biochem Biophys Res Commun 251:339-343.